---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-105533"
form_type: "8-K"
ticker: "DMRA"
cik: "0001800315"
company_name: "Damora Therapeutics, Inc."
filed_at: "2024-09-11T23:59:59+00:00"
generated_at: "2026-05-31T05:28:32.960496+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Galecto completes 1-for-25 reverse stock split; post-split shares at 1,248,266

## Summary
- Reverse stock split effective August 29, 2024; every 25 shares converted to 1 share.
- Computershare confirms total outstanding shares post-split: 1,248,266.
- Fractional shares resulting from the reverse split were rounded up to the nearest whole share.

## SEC filing metadata
- accession: 0000950170-24-105533
- form_type: 8-K
- ticker: DMRA
- cik: 0001800315
- company_name: Damora Therapeutics, Inc.
- filed_at: 2024-09-11T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1800315/000095017024105533/0000950170-24-105533-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1800315/000095017024105533/glto-20240910.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-105533
- JSON: https://secwatch.observer/filing/0000950170-24-105533.json
- Plain text: https://secwatch.observer/filing/0000950170-24-105533.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.